New Jersey 2022 2022-2023 Regular Session

New Jersey Senate Bill S1507 Introduced / Fiscal Note

                       
Office of Legislative Services 
State House Annex 
P.O. Box 068 
Trenton, New Jersey  08625 
 	Legislative Budget and Finance Office 
Phone (609) 847-3105 
Fax (609) 777-2442 
www.njleg.state.nj.us 
  
 
LEGISLATIVE FISCAL ESTIMATE 
[First Reprint] 
SENATE, No. 1507 
STATE OF NEW JERSEY 
220th LEGISLATURE 
 
DATED: NOVEMBER 3, 2022 
 
 
SUMMARY 
 
Synopsis: Revises and codifies schedule for childhood lead screenings; requires 
lead screenings as precondition of child's initial entry into school 
system. 
Type of Impact: Annual increase in State expenditures, annual increase in State 
revenues, potential increase in local government costs. 
Agencies Affected: Department of Human Services, Department of Education, local health 
departments. 
 
 
Office of Legislative Services Estimate 
Fiscal Impact  Annual  
State Cost Increase Indeterminate  
State Revenue Increase Indeterminate  
Potential Local Cost Increase Indeterminate  
 
 
 The Office of Legislative Services (OLS) concludes that the State Medicaid program, 
commonly known as NJ FamilyCare, will incur an indeterminate increase in annual 
expenditures under the bill in order to provide one additional lead screening test for all children 
prior to enrollment in school.  Since the majority of NJ FamilyCare beneficiaries are enrolled 
in managed care, and provider reimbursement rates negotiated by the NJ FamilyCare managed 
care organizations are proprietary information, State costs to provide the additional blood tests 
are uncertain.  
 To the extent that the federal government provides matching funds for qualifying State 
Medicaid expenditures, State revenues will also increase by an indeterminate amount from 
federal reimbursements. 
 Any increase in the number of children undergoing lead screenings will almost certainly 
increase costs for local boards of health, which provide case management services for children 
with elevated blood lead levels and their families.  Because the number of children who will  FE to S1507 [1R] 
2 
 
be referred to a local board of health for case management services is unpredictable, the fiscal 
impact on local governments cannot be estimated. 
 
 
BILL DESCRIPTION 
 
 This bill amends current State requirements for childhood lead screening by: (1) codifying the 
Department of Health’s existing schedule for required childhood lead screening; (2) increasing the 
number of required childhood lead screening tests from two to three, with the third screening test 
to be conducted immediately prior to the child’s enrollment in school; and (3) requiring a child’s 
parent or guardian to provide the child’s school with documentation showing the child’s lead 
screening results, as a precondition of the child’s initial entry into the school system. Existing 
State regulations require primary care providers to screen a child for elevated blood lead levels at 
the ages of 12 months and again at 24 months.  Primary care providers are also currently required 
to conduct a lead screening for a child under the age of six years, who has not previously been 
tested. 
 Pursuant to the bill, the department will develop an educational outreach campaign to inform 
parents and guardians, as well as health care providers, about the updated lead screening schedule 
and conditions for initial school enrollment.  The bill additionally requires the department to update 
its existing lead screening public information campaign to reflect the requirements established 
pursuant to the bill.  Any information disseminated through the public information and educational 
outreach campaigns is to be publicly posted on the department’s website. 
 The bill clarifies that any departmental regulations concerning the provision of insurance 
coverage for childhood lead screenings are to be consistent with the revisions to the State’s lead 
screening laws adopted under the bill.  
 
 
FISCAL ANALYSIS 
 
EXECUTIVE BRANCH 
 
 None received. 
 
OFFICE OF LEGISLATIVE SERVICES 
 
 The OLS concludes that the State will incur an indeterminate annual increase in expenditures 
under the bill, due to the requirement that all young children undergo one additional lead screening 
test prior to enrollment in a pre-kindergarten class or a kindergarten class.  Pursuant to current law, 
most private insurers and the NJ FamilyCare program cover the cost of required lead screening 
tests with no cost sharing.  As such, the NJ FamilyCare program costs would increase in order to 
provide one additional lead screening test for all enrolled children under the age of six years.  
Because greater than 95 percent of NJ FamilyCare beneficiaries are enrolled in managed care, and 
provider reimbursement rates negotiated by the NJ FamilyCare managed care organizations are 
proprietary information, the additional costs accruing to the State under the bill cannot be 
incorporated into this analysis. To the extent that the federal government provides matching funds 
for qualifying State Medicaid expenditures, State revenues will also increase by an indeterminate 
amount from federal reimbursements.   
 For context, the Department of Health’s Childhood Lead Exposure in New Jersey Annual 
Report shows that 139,596 children, or 21.4 percent of children under the age of six years in the  FE to S1507 [1R] 
3 
 
State, were screened for lead during FY 2020. However, this rate is likely somewhat low given 
the temporary moratorium on non-essential in-person medical care put in place toward the end of 
FY 2020 during the COVID-19 pandemic.  Of the children undergoing lead screening tests in FY 
2020, 2.1 percent had elevated blood lead levels.   
 Any increase in the number of required childhood lead screening tests will almost certainly 
increase the number of test results showing elevated blood lead levels among young children.  
According to guidance published by the department, families without health insurance may access 
childhood lead screenings at their local department of health.  Moreover, departmental regulations 
stipulate that local boards of health are responsible for providing case management services for 
children with confirmed elevated blood lead levels.  Case management services provided by local 
boards of health may include, but are not limited to: referrals for medical evaluation and care, 
monitoring blood lead retesting, providing caregiver education and counseling, and arranging for 
lead screening for siblings.  Because the number of children who may be referred to a local board 
of health for case management services, and the specific services that a child may require, is 
unknown, this analysis cannot quantify the increased costs that local boards of health will likely 
incur under the bill.   
 The Department of Health will incur marginal costs to update its existing lead screening public 
information campaign to inform parents, guardians, and health care providers about the revised 
lead screening schedule and requirements.  The OLS assumes that the department will utilize the 
materials from the public information campaign to implement the public educational outreach 
campaign established under the bill. 
 Finally, the Department of Education will realize marginal additional costs to update its 
regulations to incorporate the revised childhood lead screening schedule for children entering 
school beginning with the 2024-2025 school year.   
 As of October 28, 2021, the Centers for Disease Control and Prevention revised its elevated 
blood lead level downward from 5 micrograms per deciliter to 3.5 micrograms per deciliter.  Lead 
screening of children consists of two components: (1) a verbal risk assessment, done by a primary 
care provider during each of a child’s well visits between the ages of six months and six years; and 
(2) a capillary or venous blood test conducted at the ages of 12 months and 24 months.  If the blood 
tests reveal an elevated blood lead level, the child will be retested.  If the second test also shows 
that a child has an elevated blood lead level, the child will be referred for follow-up medical care 
and the child’s family will receive case management services from the local board of health.  
 
 
Section: Human Services 
Analyst: Anne Cappabianca 
Associate Fiscal Analyst 
Approved: Thomas Koenig 
Legislative Budget and Finance Officer 
 
 
This legislative fiscal estimate has been produced by the Office of Legislative Services due to the 
failure of the Executive Branch to respond to our request for a fiscal note. 
 
This fiscal estimate has been prepared pursuant to P.L.1980, c.67 (C.52:13B-6 et seq.).